Bernhard Nocht Institute for Tropical Medicine

What Bernhard Nocht Institute for Tropical Medicine does

Bernhard Nocht Institute for Tropical Medicine (BNITM) is a Hamburg-based research foundation under public law, founded in 1900 and a member of the Leibniz Association. With 400+ employees, it is Germany's largest institution dedicated to tropical and emerging infectious diseases, operating BSL-4 and BSL-3 laboratories that enable handling of high-consequence pathogens including Ebola, Lassa, and West Nile viruses. Its core activities span basic and translational research, reference diagnostics for tropical pathogens, and the delivery of structured training programs for clinicians and laboratory scientists.

BNITM operates a portfolio of designated infrastructure assets that anchor its market position, including a National Reference Center for tropical pathogens and two WHO Collaborating Centres (for Virus Metagenomics and for Arbovirus and Hemorrhagic Fever Reference and Research). It maintains a network of mobile laboratories across seven East African Community countries, established in 2017, and extended into antimicrobial resistance surveillance from 2020. The institute also hosts the EU-funded MOBILISE project for a green mobile One Health laboratory (launched 2022) and the GC-ADAPT center in Costa Rica focused on climate-adapted infectious diseases. Scientific outputs are recurring and high-tier, including recent publications in Nature Microbiology (Ebola organoid persistence, 2026), Eurosurveillance (West Nile Virus spread, 2026), and Lancet Microbe (Lassa persistence, 2021).

The institute's revenue model is multi-source public funding combined with fee-based diagnostics, training, and donor income. Anchor funding flows from German federal ministries (BMG, BMBF, BMZ via KfW), the Hamburg state authority (BWFG), DFG, and the EU. Supplemental revenue is generated through diagnostic services, professional training courses, alumni-platform services (GO4BSB), merchandise, and memberships through the Verein der Freunde. The Board of Directors comprises Prof. Jürgen May (Chairman), Prof. Stephan Günther (Deputy), Prof. Iris Bruchhaus (Board Member), and Birgit Müller (Managing Director).

Name

Bernhard Nocht Institute for Tropical Medicine

Legal name

Bernhard-Nocht-Institut für Tropenmedizin

Website

https://bnitm.de

Company type

Private

Founded year

1900

Operating status

Operating

Headcount range

101–250 employees

Short description

BNITM is Germany's largest tropical and emerging infectious disease research institute, operating BSL-4 laboratories, delivering reference diagnostics and training, and running a mobile laboratory network across East African Community countries for outbreak response.

Ownership category

akta.pro rank

Product category

Tropical and Emerging Infectious Disease Research

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Regional/State Public Health Laboratories (HLAJAIAB)

akta.pro secondary industries

Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD), Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks (HLAJAIAN), Public Health Laboratories & Diagnostic Oversight (BPAIAJAF)

Keywords

• Tropical medicine research
• Infectious disease diagnostics
• Outbreak response laboratories
• BSL-4 high containment
• Global health training

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Government Funding: Core funding from German federal government (Bundesministerium für Gesundheit, Bundesministerium für Bildung und Forschung) and Hamburg state government (Behörde für Wissenschaft, Forschung, Gleichstellung)
2. Research Grants and Project Funding: Competitive research grants from DFG, EU Horizon programs, German Alliance for Global Health Research (GLOHRA), and international funding bodies
3. Training Course Fees: Revenue from professional training courses including DTM&H, medical courses, bioinformatics summer schools, and international education programs
4. Diagnostic Services: Central laboratory diagnostics and MVZ (medical care center) services; National Reference Center functions for tropical pathogens
5. Donations and Membership Fees: Association of Friends (VdF) membership fees (€50 annually) and donations from supporters; sponsorships and bequests
6. Development Cooperation Funding: Funding from German Federal Ministry for Economic Cooperation and Development (BMZ) through KfW for international capacity building projects in Africa

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

BNITM conducts research, diagnostics, and training on tropical and emerging infectious diseases. It operates BSL-4 and BSL-3 containment laboratories, a National Reference Center for tropical pathogens, WHO Collaborating Centres for arboviruses and behavioural global health research, deployable mobile diagnostic laboratories across East Africa, and an international portfolio of professional training and summer school programs.

Product overview

BNITM is Germany's largest research institution for tropical and emerging infectious diseases, combining research, diagnostics, and education services. The core offerings include: mobile diagnostic laboratories for rapid deployment in outbreak situations (EAC Mobile Labs); high-security laboratory infrastructure (BSL-4 and BSL-3 Insectarium) for researching dangerous pathogens; comprehensive laboratory diagnostic services including National Reference Center functions and WHO Collaborating Center activities for arboviruses and hemorrhagic fever viruses; and international training programs (DTM&H, summer schools, iACE Global Health) for capacity building. The institute operates the GO4BSB alumni platform for continued biosecurity education and provides research services through specialized groups in virus metagenomics, health economics, and infectious disease epidemiology. The mobile laboratories and research infrastructure form the foundation for outbreak response capabilities across East Africa and beyond.

Differentiator

Problem solved

Functional benefit

Products and services

• Mobile Laboratories (EAC Mobile Labs)
• Central Laboratory Diagnostics & MVZ
• Training and Education Programs (DTM&H, Summer Schools, iACE Global Health)
• National Reference Center for Tropical Pathogens
• WHO Collaborating Centre for Arboviruses and Hemorrhagic Fever Viruses
• Virus Metagenomics and Evolution Research Services
• GO4BSB Alumni Platform
• Health Economics Research Services
• Association of Friends (VdF) Membership and Donation Program

Quantifiable outcome

• Mobile laboratory network deployed across 9 sites in 7 EAC countries for rapid outbreak response
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability7 records

Feature7 records

Partnerships

Nine partnerships are on record, tiered core.

• East African Community (EAC)coreStrategic or Co-development Partner · 1 January 2017Multi-year partnership to establish and maintain a network of 9 mobile BSL3/4 laboratories across 7 EAC partner countries (Tanzania, Uganda, Kenya, Rwanda, Burundi, South Sudan, DRC). BNITM provides technical expertise, training, and equipment. The network enables rapid outbreak response and disease surveillance in the region. Funded by BMZ through KfW.
• Icahn School of Medicine at Mount Sinai (ISMMS)coreStrategic or Co-development PartnerJoint research collaboration on Ebola virus persistence using brain organoid models. Includes researchers from ISMMS and NIH's Integrated Research Facility. Joint publication in Nature Microbiology (2026).
• Irrua Specialist Teaching Hospital (ISTH), NigeriacoreStrategic or Co-development PartnerLong-standing research partnership (10+ years) on Lassa fever. Joint prospective longitudinal study on viral persistence in body fluids. Research findings published in Lancet Microbe.
• WHO Collaborating Centre for Arboviruses / Hemorrhagic Fever VirusescoreStrategic or Co-development PartnerOfficial WHO designation for coordinating global surveillance and response to arboviruses and hemorrhagic fever viruses.
• WHO Collaborating Centre for Behavioural Research in Global HealthcoreStrategic or Co-development PartnerOfficial WHO designation supporting behavioral research initiatives for global health improvement.
• German-Costa Rican Center for Climate Adaptation and Infectious Diseases (GC-ADAPT)coreStrategic or Co-development PartnerJoint center with Costa Rican National Health Institute (INCIENSA) and National Meteorological Institute (IMN) investigating climate change impacts on infectious disease emergence and transmission.
• German Center for Infection Research (DZIF)coreStrategic or Co-development PartnerNational research network providing funding and coordination for infectious disease research across German institutions.
• University Medical Center Hamburg-Eppendorf (UKE)coreStrategic or Co-development PartnerJoint research on Ebola virus using brain organoid models; clinical research collaboration; shared infrastructure and expertise.
• Nigerian Centre for Disease ControlcoreStrategic or Co-development PartnerCollaboration with national public health authority for Lassa fever research and outbreak response coordination.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Institute of Tropical Medicine Antwerp (ITM): ITM is a Belgian public research and teaching institute focused on tropical and travel medicine, clinical reference diagnostics, and capacity building in the Global South, closely mirroring BNITM's research-diagnostics-training triad.
• Robert Koch Institute (RKI): RKI is Germany's federal public health agency, coordinating national infectious disease surveillance, reference centers, and outbreak response — a domestic peer that shares BNITM's regulatory mandate framework within the German public-health architecture.
• London School of Hygiene & Tropical Medicine (LSHTM): LSHTM is a leading postgraduate tropical and public health research and training institution with extensive global partnerships in Africa and Asia, comparable to BNITM in mission, training portfolio, and global-health research output.
• Liverpool School of Tropical Medicine (LSTM): LSTM is one of the world's oldest tropical medicine research and teaching institutions, offering diagnostic reference services, postgraduate training, and field-research programs in Africa and Asia — a direct historical and functional peer to BNITM.
• Swiss Tropical and Public Health Institute (Swiss TPH): Swiss TPH is a public-law institute affiliated with the University of Basel that combines tropical medicine research, diagnostic reference laboratory services, training, and global health capacity building — the closest structural analogue to BNITM in continental Europe.
• Mahidol Oxford Tropical Medicine Research Unit (MORU): MORU is a tropical medicine research collaboration based in Bangkok conducting clinical and field research on malaria, tropical infections, and outbreak response across Asia and Africa, comparable to BNITM in research breadth and Asia/Africa field presence.

Broad incumbents

• Institut Pasteur: Institut Pasteur is a large, internationally distributed research foundation with deep expertise in infectious diseases, reference laboratory networks, and WHO collaborating centres, operating at greater scale and scope than BNITM but in overlapping pathogen domains.
• Centers for Disease Control and Prevention (CDC): CDC is the U.S. federal public health agency operating global infectious disease surveillance, reference laboratories, and outbreak response — substantially larger and broader than BNITM but with overlapping capabilities in tropical pathogens and field laboratory deployment.

Emerging players

• Institut de Recherche pour le Développement (IRD): IRD is a French public research organization conducting interdisciplinary research in tropical and developing countries with strong focus on infectious diseases, ecosystems, and One Health, overlapping with BNITM's research and capacity-building model in Francophone Africa.

Regional players

• National Institute for Communicable Diseases (NICD), South Africa: NICD is South Africa's national public health institute for communicable disease surveillance, reference diagnostics, and outbreak response in Africa, making it a regional peer in pathogen focus and mission that complements BNITM's EAC footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bernhard-nocht-institute-for-tropical-medicine
• Instagraminstagram.com/bnitm_de
• Xx.com/bnitm_de

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bernhard Nocht Institute for Tropical Medicine